Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Progesterone for pregnant women with a short cervix to prevent preterm birth
NL-OMON35507Phase 3Not yet recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Feb 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in preterm birth comparing Vaginal progesterone with Placebo (2 arms). Primary endpoint: Bad neonatal outcome. Planned start Feb 2009; status: not yet recruiting.
02
Drugs
progesterone
03
Conditions
preterm birth
Beyond the preview
Go deeper on NL-OMON35507.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON35507.